People news: Nycomed US, Vitae and Taris Biomedical

Share this article:
Nycomed US hired Steve Andrzejewski as CEO, putting him in charge of Nycomed's US dermatology business and distribution and commercial operations for the three marketing and sales divisions Fougera, PharmaDerm and Savage Laboratories. Andrzejewski has been working in healthcare for more than 20 years, having joined from King Pharmaceuticals, where he served as corporate head, commercial operations first and then as chief commercial officer.

Vitae Pharmaceuticals hired Christine Brennan, PhD as chief business officer. Most recently, she served as executive director and head of strategy and operations for strategic alliances at Novartis' Institutes for BioMedical Research.

Specialty firm Taris Biomedical hired Sarma Duddu, PhD, as president, CEO and board member, effective immediately. Taris focuses on the field of drug-device convergence for targeted therapies, and Sarmu has been involved in all aspects of the drug-delivery business during a 15-year career. Most recently, he was general manager and VP of worldwide drug-delivery technologies for Cima Labs, a Cephalon unit, and prior to that served as VP of pharmaceutical development at Nektar Therapeutics.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in People Moves

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media